替罗非班治疗缺血性脑血管病的研究进展  

Research Progress of Tirofiban in the Treatment of Ischemic Cerebrovascular Diseases

作　　者：黎文彬 刘铮[2] 李志刚[2] LI Wenbin;LIU Zheng;LI Zhigang(The First Clinical Medical School,Gannan Medical University,Ganzhou 314000,China;不详)

机构地区：[1]赣南医学院第一临床医学院,江西赣州314000 [2]赣南医学院第一附属医院

出　　处：《中国医学创新》2023年第24期183-188,共6页Medical Innovation of China

摘　　要：急性缺血性脑血管病严重危害人类的健康,抗血小板治疗是急性缺血性脑血管病极其重要的治疗方法,替罗非班是新型抗血小板药物之一。本文对目前国内外替罗非班治疗缺血性脑血管病的研究进行总结,为缺血性脑血管病抗血小板治疗提供新思路。Acute ischemic cerebrovascular disease is seriously harmful to human health.Antiplatelet therapy is a very important treatment for acute ischemic cerebrovascular disease.Tirofiban is one of the new antiplatelet drugs.This article summarizes the current research on Tirofiban in the treatment of ischemic cerebrovascular disease at home and abroad,in order to provide a new idea for antiplatelet therapy of ischemic cerebrovascular disease.

关 键 词：替罗非班 缺血性脑血管病 综述 

分 类 号：R743[医药卫生—神经病学与精神病学]